4 Results for "

Nebracetam

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Nebracetam" in MCE Product Catalog:

Cat. No.: HY-P10736
Target:  

GCGR

Research Areas:  

Metabolic Disease

AMG133 peptide payload is a GLP-1 analog agonist peptide. AMG133 peptide potently activates GLP-1R, and exhibits weight loss and metabolic improvement activities. AMG133 peptide payload can be used for the synthesis of AMG 133 (HY-164535) .
loading...
    loading...
Cat. No.: HY-P10736A
Target:  

GCGR

Research Areas:  

Metabolic Disease

AMG133 peptide payload TFA is a GLP-1 analog agonist peptide. AMG133 peptide payload TFA potently activates GLP-1R and exhibits weight loss and metabolic improvement activities. AMG133 peptide payload TFA can be used for the synthesis of AMG 133 (HY-164535) .
loading...
    loading...
Cat. No.: HY-113970A
CAS No.: 1177279-49-0
Purity:  ≥99.0%
Synonyms: WEB 1881 FU hydrochloride
Target:  

mAChR Calcium Channel

Research Areas:  

Neurological Disease

Nebracetam (WEB 1881 FU) hydrochloride is an orally active M1 muscarinic receptor agonist. Nebracetam hydrochloride can induce an increase in intracellular Ca 2+ concentration, with an EC50 value of 1.59 mM. Nebracetam hydrochloride exhibits neuroprotective activity and the ability to improve cognitive impairment. Nebracetam hydrochloride can be used in the research of neurological diseases such as Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-113970
CAS No.: 97205-34-0
Synonyms: WEB 1881 FU
Target:  

mAChR Calcium Channel

Research Areas:  

Neurological Disease

Nebracetam (WEB 1881 FU) is an orally active M1 muscarinic receptor agonist. Nebracetam can induce an increase in intracellular Ca 2+ concentration, with an EC50 value of 1.59 mM. Nebracetam exhibits neuroprotective activity and the ability to improve cognitive impairment. Nebracetam can be used in the research of neurological diseases such as Alzheimer's disease .
loading...
    loading...